Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP935450.RASMyv-FIkl28e4nqbZdBhEn6We0mwWWTO8GEnzlL5BEw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP935450.RASMyv-FIkl28e4nqbZdBhEn6We0mwWWTO8GEnzlL5BEw130_assertion type Assertion NP935450.RASMyv-FIkl28e4nqbZdBhEn6We0mwWWTO8GEnzlL5BEw130_head.
- NP935450.RASMyv-FIkl28e4nqbZdBhEn6We0mwWWTO8GEnzlL5BEw130_assertion description "[In 1994, the field of bone biology was significantly advanced by the discovery that activating mutations in the fibroblast growth factor receptor 3 (FGFR3) receptor tyrosine kinase (TK) account for the common genetic form of dwarfism in humans, achondroplasia (ACH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP935450.RASMyv-FIkl28e4nqbZdBhEn6We0mwWWTO8GEnzlL5BEw130_provenance.
- NP935450.RASMyv-FIkl28e4nqbZdBhEn6We0mwWWTO8GEnzlL5BEw130_assertion evidence source_evidence_literature NP935450.RASMyv-FIkl28e4nqbZdBhEn6We0mwWWTO8GEnzlL5BEw130_provenance.
- NP935450.RASMyv-FIkl28e4nqbZdBhEn6We0mwWWTO8GEnzlL5BEw130_assertion SIO_000772 22045636 NP935450.RASMyv-FIkl28e4nqbZdBhEn6We0mwWWTO8GEnzlL5BEw130_provenance.
- NP935450.RASMyv-FIkl28e4nqbZdBhEn6We0mwWWTO8GEnzlL5BEw130_assertion wasDerivedFrom befree-2016 NP935450.RASMyv-FIkl28e4nqbZdBhEn6We0mwWWTO8GEnzlL5BEw130_provenance.
- NP935450.RASMyv-FIkl28e4nqbZdBhEn6We0mwWWTO8GEnzlL5BEw130_assertion wasGeneratedBy ECO_0000203 NP935450.RASMyv-FIkl28e4nqbZdBhEn6We0mwWWTO8GEnzlL5BEw130_provenance.